ピオグリタゾンは内臓脂肪代謝を低下させる

基本情報

NCT ID: NCT01819402
ステータス: 不明
試験のフェーズ: 該当なし
試験タイプ: 介入
目標被験者数: 60
治験依頼者名: Kurume University

概要

Excess visceral fat is associated with chronic systemic inflammation and cardiovascular complications. Pioglitazone has been reported to variably influence visceral fat volume, but it its effect on metabolic activity of the visceral fat remains uncharacterized. To evaluate the effect of pioglitazone on glucose metabolism of fat tissue by using 18F-fluorodeoxyglucose (FDG)-positron emission tomography (PET) and computed tomography (CT) imaging.

対象疾患

To Evaluate the Effect of Pioglitazone on Glucose Metabolism of Fat Tissue by Using FDG-PET/CT Imaging

介入

Pioglitazone vs Glimepiride(DRUG)

依頼者（Sponsor）

Kurume University(OTHER)

実施施設 (1)

Kurume University

Kurume, Japan(RECRUITING)